Brokerages Set Teladoc Health, Inc. (NYSE:TDOC) Target Price at $12.24

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been assigned a consensus rating of “Hold” from the twenty-one analysts that are currently covering the firm, Marketbeat Ratings reports. Fourteen research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $12.24.

Several equities research analysts have issued reports on TDOC shares. Evercore ISI raised their target price on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. TD Cowen cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Barclays upped their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Finally, The Goldman Sachs Group assumed coverage on shares of Teladoc Health in a report on Friday, November 15th. They issued a “buy” rating and a $14.00 price objective on the stock.

Teladoc Health Stock Performance

Shares of TDOC opened at $9.52 on Thursday. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $22.16. The firm has a market capitalization of $1.64 billion, a P/E ratio of -1.65 and a beta of 0.97. The firm has a 50-day moving average price of $9.89 and a 200 day moving average price of $9.04. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Sell-side analysts forecast that Teladoc Health will post -1.16 EPS for the current year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.95% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently modified their holdings of the company. Bank of New York Mellon Corp lifted its stake in Teladoc Health by 1.7% during the second quarter. Bank of New York Mellon Corp now owns 916,129 shares of the health services provider’s stock worth $8,960,000 after purchasing an additional 14,910 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of Teladoc Health by 22.8% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 25,250 shares of the health services provider’s stock valued at $247,000 after buying an additional 4,682 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Teladoc Health by 2.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider’s stock worth $641,000 after acquiring an additional 1,352 shares in the last quarter. Principal Financial Group Inc. lifted its position in Teladoc Health by 27.8% in the second quarter. Principal Financial Group Inc. now owns 17,674 shares of the health services provider’s stock valued at $173,000 after acquiring an additional 3,841 shares during the last quarter. Finally, Signaturefd LLC lifted its position in Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after acquiring an additional 1,715 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.